ArticleCureus2026
Evaluation of Retinal Histological Alterations Following Carbamazepine Administration in Adult Albino Wistar Rats.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Epilepsy is characterized by recurrent, unprovoked seizures and is a major global chronic neurological public health concern. Objective To evaluate retinal histological alterations, focusing on retinal ganglion cell count and apoptosis, following carbamazepine (CBZ) administration in adult albino Wistar rats. It is an antiepileptic drug mainly used for focal (partial) seizures, where it suppresses excessive neuronal firing by blocking voltage-gated Na⁺ channels. Study design A randomized, controlled experimental design was used. Methodology In the present study, 18 adult albino Wistar rats were given carbamazepine formulated in alkalinized sodium hydroxide (NaOH) according to their body weight. Following the experimental period, retinal tissues were harvested, fixed, and processed for immunohistochemical analysis using standard staining procedures and DAB (3,3'-diaminobenzidine) visualization. DAB visualization is a method in immunohistochemistry in which the DAB substrate reacts with the enzyme HRP (horseradish peroxidase) to produce an insoluble brown-colored precipitate at the site of the target antigen, allowing microscopic visualization and localization of the protein. Microscopic evaluation was performed to assess retinal ganglion cell density and apoptotic cell count per mm² across retinal layers using an ocular grid under 40X magnification. Animals were randomly divided into three groups (n=6 per group) using the balloting method. Group A was labelled as the control, while Groups B and C were labelled as experimental groups. Statistical analysis All the data were processed by SPSS v26.0 (IBM Corp., Armonk, USA). Kruskal-Wallis test was applied to compare means of scores, and one-way ANOVA was applied to compare means of numerical variables of all three groups. Results Retinal ganglion cell (RGC) count was observed to be reducing from the control group to experimental Group C. Mean±SD of RGC in Group A was 35.76±3.47, in Group B it was 27.80-±1.47, and in Group C it was 18.63±1.13. Results showed the difference was overall significant (p< 0.001). The control group showed few apoptotic sites, while experimental groups showed enhanced dose-dependent expression, which was moderate in Group B and greatly enhanced in Group C. Conclusion We concluded that carbamazepine administration can result in dose-dependent histological alterations in the retina, including retinal ganglion cell loss, layer disorganization, and increased apoptosis, particularly in the retinal pigment epithelium. Further studies are recommended to investigate the underlying mechanisms and determine the long-term retinal safety of carbamazepine, particularly at higher doses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.